{"id":"NCT02469246","sponsor":"Gilead Sciences","briefTitle":"Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC","officialTitle":"A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-29","primaryCompletion":"2017-12-11","completion":"2019-03-13","firstPosted":"2015-06-11","resultsPosted":"2018-06-11","lastUpdate":"2019-10-25"},"enrollment":567,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["HIV-1 Infection"],"interventions":[{"type":"DRUG","name":"F/TAF","otherNames":["DescovyÂ®"]},{"type":"DRUG","name":"ABC/3TC","otherNames":[]},{"type":"DRUG","name":"ABC/3TC Placebo","otherNames":[]},{"type":"DRUG","name":"F/TAF Placebo","otherNames":[]},{"type":"DRUG","name":"3rd ARV agent","otherNames":[]}],"arms":[{"label":"F/TAF (Double-Blind)","type":"EXPERIMENTAL"},{"label":"ABC/3TC (Double-Blind)","type":"ACTIVE_COMPARATOR"},{"label":"Open-Label F/TAF","type":"EXPERIMENTAL"}],"summary":"The primary objectives of this study are to evaluate the efficacy, safety, and tolerability of switching abacavir/lamivudine (ABC/3TC) fixed-dose combination (FDC) tablets to emtricitabine/tenofovir alafenamide (F/TAF) FDC tablets versus maintaining ABC/3TC in human immunodeficiency virus type 1 (HIV-1) infected adults who are virologically suppressed on regimens containing ABC/3TC.","primaryOutcome":{"measure":"Percentage of Participants With HIV-1 RNA < 50 Copies/mL at Week 48 as Determined by the FDA-Defined Snapshot Algorithm","timeFrame":"Week 48","effectByArm":[{"arm":"F/TAF","deltaMin":88.6,"sd":null},{"arm":"ABC/3TC","deltaMin":92.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.15"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":12},"locations":{"siteCount":80,"countries":["United States","Belgium","Canada","Denmark","France","Germany","Ireland","Italy","Puerto Rico","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["29475804","30932951"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":55,"n":280},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Diarrhoea","Cough","Arthralgia"]}}